Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Actinogen, Ascletic, Biontech, Gannex, Genome, Incannex, Innocare, Pharmbacine, Recce, Sciwind.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adagene, Chipscreen Newway, Golden Biotechnology, Hope Medicines, Junshi.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Delta-Fly, GPN Vaccines, Immutep, Jiangsu Recbio, Gannex Pharma, Belief Biomed, Innovent, Sciwind.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Caliway, Carina Biotech, Clairy, CSL, Daiichi, Highfield, Innocare, Lynx, Neuren, Shapiron, Sumitomo, Yoltech.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 1st Biotherapeutics, Alebund, Clover, Dizal, Hutchmed Imagion, Qilu.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Bionomics, Innovent, Merck, Neuren, Qulu, Ribomic, Technoderma.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adlai Nortye Biopharma, Aribio, Brii Biosciences, Certa Therapeutics, Neuren Pharmaceuticals, SCG Cell Therapy, Visen Pharmaceuticals.